| 000 | 01132 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512073249.0 | ||
| 264 | 0 | _c19870407 | |
| 008 | 198704s 0 0 eng d | ||
| 022 | _a0271-0749 | ||
| 024 | 7 |
_a10.1097/00004714-198702000-00034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobinson, D S | |
| 245 | 0 | 0 |
_aWhat is the degree of risk of hepatotoxicity for depressed patients receiving phenelzine therapy? Is the risk sufficient to require that we modify the written advice (as to diet and risks) that we regularly give our patients before we institute this therapy? _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cFeb 1987 |
||
| 300 |
_a61-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aDepression _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aPhenelzine _xadministration & dosage |
| 650 | 0 | 4 | _aRisk |
| 700 | 1 | _aKurtz, N M | |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 7 _gno. 1 _gp. 61-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004714-198702000-00034 _zAvailable from publisher's website |
| 999 |
_c3824690 _d3824690 |
||